The development of caffeine immunoassays has been driven by the clinical need to determine caffeine levels in human body fluids. A radioimmunoassay was developed in the mid 1970s to measure caffeine in plasma and saliva in concentrations higher than 25 µg L−1(Cook et al 1976). The main barrier for i...